Interview: Medicines for Europe Reports on EU Biosimilar Success

27 July 2020

The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven, […]

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy

9 July 2020

Urgent call for a structured industry-EU dialogue on reform The […]

IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe

30 June 2020

Good biosimilar medicine policies balance the benefits of multi-source competition, […]

EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from Covid19

4 June 2020

Letter to EU Trade Ministers. European Industry trade and supply chain needs to respond to Covid-19

10 April 2020

A statement from the President on COVID-19

8 April 2020

Medicines for Europe welcomes European Commission decision to enable secure supply of hospital medicines

8 April 2020

Statement: Supply of essential ICU medicines

2 April 2020

European Commission guidelines: Free movement of workers during COVID-19 outbreak

30 March 2020